<DOC>
	<DOCNO>NCT02013622</DOCNO>
	<brief_summary>The purpose study investigate effect flexibly dose Brexpiprazole monotherapy improvement early-episode schizophrenia assessment social functioning , efficacy , tolerability . Early-episode schizophrenia define episode occur ≤ 5 year onset first episode .</brief_summary>
	<brief_title>Monotherapy Brexpiprazole ( OPC-34712 ) Trial Treatment Adults With Early-Episode Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Have diagnosis schizophrenia define Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) confirm Mini International Neuropsychiatric Interview ( M.I.N.I . ) Schizophrenia Psychotic Disorders Studies adequate clinical psychiatric evaluation . Had start first schizophrenia episode ≤ 5 year time consent . Are 18 35 year old time consent ( inclusive , outpatient ) . Have Positive Negative Syndrome Scale ( PANSS ) Total Score ≤ 80 screen baseline . Exhibit schizophrenia symptom score ≥ 4 PANSS ≥1 item relate active social avoidance , emotional withdrawal , passive/apathetic social withdrawal , difficulty abstract think . Have diagnosis schizophrenia make least 6 month prior screen confirm subject , caregiver , document history . Subjects present first episode schizophrenia base clinical judgment investigator . Subjects hospitalize psychotic symptom within last 6 month . Subjects schizophrenia consider resistant/refractory antipsychotic treatment history history failure respond clozapine response clozapine treatment . Subjects current DSMIVTR Axis I diagnosis schizophrenia , include , limited , schizoaffective disorder , MDD , bipolar disorder , posttraumatic stress disorder , anxiety disorder , delirium , dementia , amnestic , cognitive disorder . Also , subject borderline , paranoid , histrionic , schizotypal , schizoid , antisocial personality disorder . Subjects experience acute depressive symptom within past 30 day , accord investigator 's opinion , require treatment antidepressant . Subjects clinically significant tardive dyskinesia enrollment , determine score &gt; = 3 Item 8 AIMS screen baseline . Subjects score 5 ( severe akathisia ) BARS global clinical assessment akathisia screen baseline . Subjects meet DSMIVTR criterion substance abuse dependence within past 180 day ; include alcohol benzodiazepine , exclude nicotine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Mental Disorders</keyword>
	<keyword>Psychotic Disorders</keyword>
	<keyword>social avoidance</keyword>
	<keyword>emotional withdrawal</keyword>
	<keyword>passive/apathetic</keyword>
	<keyword>social withdrawal</keyword>
	<keyword>antipsychotic</keyword>
</DOC>